-
Mashup Score: 1UW Human Resources - 7 month(s) ago
University of Washington Human Resources
Source: uwhires.admin.washington.eduCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 15Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non–organ-confined Upper Tract Urothelial Carcinoma - 7 month(s) ago
Optimal patient selection for neoadjuvant chemotherapy prior to surgical extirpation is limited by the inaccuracy of contemporary clinical staging met…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 15
Each year the European Association of Urology (EAU) produce a document based on the most recent evidence on the diagnosis, therapy, and follow-up of testicular cancer (TC).
Source: www.europeanurology.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality | Journal of Urology - 9 month(s) ago
Can’t sign in? Forgot your password? If the address match es an existing account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? *Correspondence: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Ave, New York, NY 10017 telephone: 646-888-8233; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York Department of Epidemiology and Biostatistics,
Source: www.auajournals.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
CN was independently associated with longer OS in patients with mRCC treated with ICI in any line of therapy. Our data support consideration of CN in well selected patients with mRCC undergoing treatment with ICI.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 11 month(s) ago
AuthorsSarah P. PsutkaUniversity of Washington, Fred Hutchinson Cancer Center, Seattle, WASarah P. Psutka, Susan Veleber, Jonathan Siman, Sarah K. Holt, Samia Jannat, Jonathan L. Wright, Daniel W. Lin, John L. Gore, George Schade, Zachary Anton Annen, Heather GreenleeOrganizationsUniversity of Washington, Fred Hutchinson Cancer Center, Seattle, WA, Fred Hutchinson Cancer Center, Seattle, WA, Fred…
Source: meetings.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial - 1 year(s) ago
In patients with oligometastatic renal cell carcinoma, radiotherapy to all metastases followed by short-course pembrolizumab is safe, with a grade 3 adverse event rate of 13%. The combination is effective, with median progression-free survival of 15.6 mo and 2-yr local control of 92%.
Source: European UrologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Stage II Seminoma: Is There Something New on the Horizon? - 1 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2European Urology - 1 year(s) ago
If you don’t remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your passwordIf the address matches a valid account an email will be sent to __email__ with instructions for resetting your password …
Source: www.europeanurology.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 23Epidemiology of Renal Cell Carcinoma: 2022 Update - 1 year(s) ago
We explored the global incidence and mortality of kidney cancer as well as its risk factors. We also highlight germline and somatic mutations that predispose to kidney cancer development. The data provide an insight into the complexity of kidney cancer epidemiology and germline and somatic mutations in patients at risk of developing kidney cancer.
Source: European UrologyCategories: Latest Headlines, Oncologists1Tweet
Exciting news! We are hiring a Research Coordinator Lead @uwurology! This role is a fantastic opportunity to bring your experiences in and passion for clinical trials and bladder cancer research to our collaborative & supportive team! Come join us! https://t.co/BQkcJn4Alt